Studies on the human tumor nucleolar antigens

Area of Science:

• Oncology
• Immunohistochemistry
• Biochemistry

Background:

• A common nucleolar antigen has been identified in various human malignant tumors.
• This antigen's presence and distribution may serve as a diagnostic marker for cancer.

Purpose of the Study:

• To investigate the presence of a common nucleolar antigen in benign and malignant breast tumors.
• To evaluate the diagnostic potential of nucleolar immunofluorescence for distinguishing cancerous from non-cancerous breast lesions.

Main Methods:

• Immunofluorescence using rabbit antibodies against human nucleolar preparations and fluorescein-labeled goat antirabbit antibodies.
• Isoelectric focusing on polyacrylamide gels to partially characterize the tumor nucleolar antigens.
• Blind study evaluating the accuracy of nucleolar fluorescence in identifying malignant versus benign breast samples.

Main Results:

• Bright nucleolar immunofluorescence was observed in 95% of known breast cancer specimens.
• In a blind study, nucleolar fluorescence correctly identified 94% of unknown breast samples as malignant or benign.
• The assay demonstrated high accuracy in identifying malignant tumors (98%) and benign/normal specimens (95%).
• Partially characterized tumor nucleolar antigens showed isoelectric points (pI) of 6.3 (major) and 6.1 (minor).

Conclusions:

• The nucleolar antigen is a reliable marker for differentiating malignant human tumors, including breast cancer, from normal and benign tissues.
• Nucleolar immunofluorescence shows significant potential as a diagnostic tool in surgical pathology for cancer detection.
• Further characterization of these tumor-associated nucleolar antigens may reveal their specific roles in tumorigenesis.